Artemis Therapeutics Inc. (OTCMKTS:ATMS) Short Interest Update

Artemis Therapeutics Inc. (OTCMKTS:ATMSGet Rating) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 1,800 shares, a growth of 38.5% from the May 31st total of 1,300 shares. Based on an average daily trading volume, of 8,900 shares, the days-to-cover ratio is presently 0.2 days.

OTCMKTS:ATMS opened at $3.75 on Friday. The company has a 50 day moving average price of $3.06 and a 200-day moving average price of $1.84. Artemis Therapeutics has a 1-year low of $0.55 and a 1-year high of $6.00.

Artemis Therapeutics (OTCMKTS:ATMSGet Rating) last posted its earnings results on Monday, May 23rd. The company reported ($0.01) EPS for the quarter.

About Artemis Therapeutics (Get Rating)

Artemis Therapeutics Inc does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc is a subsidiary of Tonak Ltd.

Further Reading

Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.